Clinical Trial Update: Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

View source ↗

Summary

This update reports the completed validation study of TRAIN-AI, an AI model, for predicting hepatocellular carcinoma recurrence after liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: European Hepatocellular Cancer Liver Transplant Group | Conditions: Hepatocellular Carcinoma (HCC), Liver Transplantation | Status: COMPLETED